It takes more than courage to cure cancer

About Us

Event Finder

February 15, 2002
Ten Dana-Farber Cancer Institute investigators chosen to receive Dunkin' Donuts 'Rising Star' grants

BOSTON – Ten junior faculty members in Dana-Farber Cancer Institute's Adult Oncology department were recently chosen to receive research grants as "Dunkin' Donuts Rising Stars."

Investigators chosen include: Lynda Chin, MD, Kornelia Polyak, MD, PhD, and Ramesh Shivdasani, MD, PhD, of Brookline; David Frank, MD, PhD, of Lexington; William Hahn, MD, PhD, and Stephanie Lee, MD, MPH, of Newton; Matt Meyerson, MD, PhD, of Concord; Geoff Shapiro, MD, PhD, of Boston; Jonathan Friedberg, MD, of Winchester; and Ted Alyea, MD, of Sherborn.

The Dunkin' Donuts Rising Stars Program was established in 1998 with a five-year, $2.5 million grant. Funding for the program comes from Dunkin' Donuts customers and franchise owners across the Northeast who support the Jimmy Fund through a variety of special programs and events such as golf tournaments. In its fourth year, the Dunkin' Donuts Rising Stars Program is supporting its largest "class" yet.

Rising Stars receive awards of $35,000 to $70,000 per year to support research that often is in its early stages, but is deemed to hold significant promise. This year's "class" was chosen after an open competition in which young researchers were invited to submit project proposals to a review committee of senior investigators.

"As a group, this year's applications were exceptional," said James Griffin, MD, of Adult Oncology at Dana-Farber, who directs the program. "Giving these 'rising stars' more resources allows them to bring their research to its maximum potential in a shorter period of time."

Dana-Farber Cancer Institute is one of the world's premier cancer care and research centers. Internationally renown for blending basic and clinical cancer research and bringing new treatments from the laboratory to the patient's bedside, Dana-Farber is a principal teaching affiliate of the Harvard Medical School.